|
Outcome title
|
Number of studies
|
Number of patients
|
Effect size (SMD [95% CI])
|
Test for overall effect p-value
|
Heterogeneity I² [%]; Tau²
|
|---|
|
Final treat-ment
| | | | | |
|
01 Pain
|
6
|
178
|
-1.17 [-2.21, -0.13]
|
0.03
|
88; 1.45
|
|
02 Fatigue
|
1
|
12
|
Not calculated
| | |
|
03 Sleep
|
2
|
66
|
Not calculated
| | |
|
04 Depressed mood
|
1
|
12
|
Not calculated
| | |
|
05 HRQOL
|
3
|
92
|
-0.90 [-2.55, 0.76]
|
0.29
|
91; 1.93
|
|
Follow up
| | | | | |
|
01 Pain
|
2
|
88
|
Not calculated *
| | |
|
02 Fatigue
|
1
|
40
|
Not calculated
| | |
|
03 Sleep
|
1
|
40
|
Not calculated
| | |
|
04 Depressed mood
|
0
|
0
| | | |
|
05 HRQOL
|
1
|
48
|
Not calculated
| | |
-
Abbreviations: HRQOL: Health-related quality of life; SMD: Standardised mean difference; CI: Confidence interval
- * Standard deviation of one study not available
